Insulin-like growth factors in poultry.
A large amount of research, primarily in mammals, has defined to a great extent the pleiotropic effects of the IGF system on growth, development, and intermediary metabolism. Similar elucidations in poultry were hindered to some extent by the absence of native peptides (IGF-I and IGF-II) until their purification, followed by the production of recombinant chicken IGFs. In many ways IGF physiology in birds is similar to that in other species, including but not limited to the fact that IGF-I synthesis is both GH- and GH-independent, and that autocrine-paracrine IGF action is evident. However, it is clear that several unique differences in IGF physiology exist between birds and mammals. For example, more IGF is present in the free form in chickens, and the biological responses to the IGFs is different in several metabolic pathways in birds compared to mammals. To date, no unique IGF-II receptor has been identified in birds. Despite an increasing understanding of the IGFs in aves, several important questions remain to be answered. What is the role of IGF-II in embryo development and posthatch growth? Does an IGF-II receptor entity exist in nonmammalian species? How does nutrition affect IGF-I and IGF-II gene expression, and can this information be used to enhance poultry production? What is the biochemical composition of the IGFBPs, and what are their roles in birds? Can the genetic variation present in poultry be used to positively modify IGF gene expression and physiology? How do the IGFs regulate intermediary metabolism? What is the role of the IGFs in the etiology of several disease states associated with rapid growth in poultry, including tibial dyschondroplasia, obesity, ascites, and spiking mortality syndrome? Answers to these questions are relevant to our understanding of the basic mechanisms of IGF physiology as well as possibly assisting in the amelioration of problems found in modern poultry production.
McMurtry
J P
JP
United States Department of Agriculture, Growth Biology Laboratory, Beltsville, MD 20705, USA.
Francis
G L
GL
Upton
Z
Z
D000595:Amino Acid Sequence; D000818:Animals; D002642:Chick Embryo / Q000254:growth & development / Q000378:metabolism / Q000502:physiology; D002645:Chickens / Q000254:growth & development / Q000378:metabolism / Q000502:physiology*; D005260:Female; D018507:Gene Expression Regulation, Developmental; D018969:Insulin-Like Growth Factor Binding Proteins / Q000235:genetics / Q000502:physiology; D007334:Insulin-Like Growth Factor I / Q000737:chemistry / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology*; D007335:Insulin-Like Growth Factor II / Q000737:chemistry / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology*; D008969:Molecular Sequence Data; D010058:Oviposition / Q000502:physiology; D011200:Poultry / Q000254:growth & development / Q000378:metabolism / Q000502:physiology*; D017451:Receptors, Somatomedin / Q000235:genetics / Q000502:physiology; D012098:Reproduction / Q000502:physiology
D018969:Insulin-Like Growth Factor Binding Proteins; D017451:Receptors, Somatomedin; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II